Investigational device for tricuspid valve replacement

Trial ID:

IRB-22-7897

Curtiss Stinis, MD

This study will evaluate the safety and effectiveness of the investigational EVOQUE System combined with optimal medical therapy (OMT) compared to OMT alone for the treatment of patients with severe or greater tricuspid regurgitation.

Be Age 18 years or older.<br>Have severe tricuspid regurgitation.<br>Be appropriate for transcatheter tricuspid valve replacement.

Contact Info:

• CRS Leadership
• CRSLeadership@scrippshealth.org